International Association for the Study of Lung Cancer(IASLC) shared a post on LinkedIn:
“New Expert Commentary on VPI in NSCLC
Dr. Ramón Rami-Porta examines the surgical implications of visceral pleural invasion (VPI) through a secondary analysis of the CALGB 140503 trial. His perspective highlights how these data may shape future staging classifications and inform surgical decision-making in early-stage NSCLC.
Read the full commentary on ILCN and consider what this could mean for clinical practice moving forward.”
Other articles about Lung Cancer on OncoDaily.